{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:23:54Z","timestamp":1763227434052,"version":"3.28.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:p>This case report describes a man in his 50s with a diffuse pruritic rash after initiating treatment with pembrolizumab and enfortumab vedotin for metastatic urothelial carcinoma.<\/jats:p>","DOI":"10.1001\/jamadermatol.2024.2722","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T15:02:11Z","timestamp":1726671731000},"page":"1251","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Pembrolizumab-Induced Mucocutaneous Lichen Planus With Metronidazole"],"prefix":"10.1001","volume":"160","author":[{"given":"Sierra","family":"Parkinson","sequence":"first","affiliation":[{"name":"University of North Carolina School of Medicine at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabah","family":"Osmani","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine at Chapel Hill"},{"name":"Department of Dermatology, University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Googe","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine at Chapel Hill"},{"name":"Department of Dermatology, University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna A.","family":"Culton","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine at Chapel Hill"},{"name":"Department of Dermatology, University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"dlo240013r1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.633032","article-title":"Association of immune related adverse events with efficacy of immune checkpoint inhibitors and overall survival in cancers: a systemic review and meta-analysis.","volume":"11","author":"Fan","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"dlo240013r2","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","article-title":"Immune checkpoint inhibitor-related dermatologic adverse events.","volume":"83","author":"Geisler","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"dlo240013r3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/ced\/llad268","article-title":"A retrospective cohort study of the efficacy of metronidazole in oral lichen planus.","volume":"48","author":"Hollis","year":"2023","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"dlo240013r4","first-page":"1186","article-title":"Efficacy of oral metronidazole in treatment of cutaneous and mucosal lichen planus.","volume":"9","author":"Rasi","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"dlo240013r5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jamadermatol.2023.3003","article-title":"Cutaneous adverse events and cancer survival prognosis with immune checkpoint inhibitor treatment: a systematic review and meta-Analysis.","volume":"159","author":"Du","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dlo240013r6","doi-asserted-by":"publisher","first-page":"160.e11","DOI":"10.1016\/j.urolonc.2023.11.017","article-title":"Antibiotic use reduces the efficacy of immune checkpoint inhibitors in patients with urothelial carcinoma: a systematic review and meta-analysis.","volume":"42","author":"Febriyanto","year":"2024","journal-title":"Urol Oncol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2823306\/jamadermatology_parkinson_2024_lo_240013_1731688990.4866.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:02:44Z","timestamp":1732118564000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2823306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.2722","relation":{},"ISSN":["2168-6068"],"issn-type":[{"type":"print","value":"2168-6068"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}